Clinical approach to diabetic Cardiomiopathy

a review of human studies

Roberto Tarquini, Laura Pala, Simona Brancati, Giulia Vannini, Salvatore De Cosmo, Gianluigi Mazzoccoli, Carlo Maria Rotella

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

BACKGROUND: Diabetic Cardiomiopathy (DC) has been defined as a distinct entity characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient in the absence of other causes for Cardiomiopathy, such as coronary artery disease (CAD), hypertension (HTN), or valvular heart disease. Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form of coronary artery disease (CAD), cardiac autonomic neuropathy or DC. The prevalence of cardiac failure is high in the diabetic population and DC is a common, but underestimated cause of heart failure in diabetes. The strong association between diabetes and heart failure has fueled intense human and animal research aimed at identifying the mechanisms underlying diabetic myocardial disease. Even if significant progress have been made, the precise pathogenesis of diabetic Cardiomiopathy is yet to be clearly defined. Hyperglycemia, dyslipidemia and inflammation are thought to play key roles in the generation of reactive oxygen or nitrogen species which are in turn involved.

METHODS: we have reviewed the up-to-date scientific literature addressing these issues.

RESULTS: The myocardial interstitium undergoes alterations resulting in abnormal contractile function noted in DC. In the early stages of the disease diastolic dysfunction is the only abnormality, but systolic dysfunction supervenes in the later stages with impaired left ventricular ejection fraction. Transmitral Doppler echocardiography is usually used to assess diastolic dysfunction, but tissue Doppler Imaging and Cardiac Magnetic Resonance Imaging are being increasingly used for early detection of DC. Diabetic patients with microvascular complications show the strongest association between diabetes and Cardiomiopathy, an association that parallels the duration and severity of hyperglycemia.

CONCLUSIONS: The management of DC involves improvement in lifestyle, control of glucose and lipid abnormalities, together with treatment of hypertension and CAD, if present.

Original languageEnglish
JournalCurrent Medicinal Chemistry
DOIs
Publication statusE-pub ahead of print - Jul 5 2017

Fingerprint

Coronary Artery Disease
Heart Failure
Medical problems
Hyperglycemia
Hypertension
Literature
Reactive Nitrogen Species
Heart Valve Diseases
Diabetic Neuropathies
Doppler Echocardiography
Dyslipidemias
Cardiomyopathies
Stroke Volume
Population
Life Style
Heart Diseases
Reactive Oxygen Species
Cardiovascular Diseases
Magnetic Resonance Imaging
Inflammation

Keywords

  • Journal Article

Cite this

Clinical approach to diabetic Cardiomiopathy : a review of human studies. / Tarquini, Roberto; Pala, Laura; Brancati, Simona; Vannini, Giulia; De Cosmo, Salvatore; Mazzoccoli, Gianluigi; Rotella, Carlo Maria.

In: Current Medicinal Chemistry, 05.07.2017.

Research output: Contribution to journalArticle

@article{e9bd17dc334046749fe1b15111479773,
title = "Clinical approach to diabetic Cardiomiopathy: a review of human studies",
abstract = "BACKGROUND: Diabetic Cardiomiopathy (DC) has been defined as a distinct entity characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient in the absence of other causes for Cardiomiopathy, such as coronary artery disease (CAD), hypertension (HTN), or valvular heart disease. Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form of coronary artery disease (CAD), cardiac autonomic neuropathy or DC. The prevalence of cardiac failure is high in the diabetic population and DC is a common, but underestimated cause of heart failure in diabetes. The strong association between diabetes and heart failure has fueled intense human and animal research aimed at identifying the mechanisms underlying diabetic myocardial disease. Even if significant progress have been made, the precise pathogenesis of diabetic Cardiomiopathy is yet to be clearly defined. Hyperglycemia, dyslipidemia and inflammation are thought to play key roles in the generation of reactive oxygen or nitrogen species which are in turn involved.METHODS: we have reviewed the up-to-date scientific literature addressing these issues.RESULTS: The myocardial interstitium undergoes alterations resulting in abnormal contractile function noted in DC. In the early stages of the disease diastolic dysfunction is the only abnormality, but systolic dysfunction supervenes in the later stages with impaired left ventricular ejection fraction. Transmitral Doppler echocardiography is usually used to assess diastolic dysfunction, but tissue Doppler Imaging and Cardiac Magnetic Resonance Imaging are being increasingly used for early detection of DC. Diabetic patients with microvascular complications show the strongest association between diabetes and Cardiomiopathy, an association that parallels the duration and severity of hyperglycemia.CONCLUSIONS: The management of DC involves improvement in lifestyle, control of glucose and lipid abnormalities, together with treatment of hypertension and CAD, if present.",
keywords = "Journal Article",
author = "Roberto Tarquini and Laura Pala and Simona Brancati and Giulia Vannini and {De Cosmo}, Salvatore and Gianluigi Mazzoccoli and Rotella, {Carlo Maria}",
note = "Copyright{\circledC} Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.",
year = "2017",
month = "7",
day = "5",
doi = "10.2174/0929867324666170705111356",
language = "English",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Clinical approach to diabetic Cardiomiopathy

T2 - a review of human studies

AU - Tarquini, Roberto

AU - Pala, Laura

AU - Brancati, Simona

AU - Vannini, Giulia

AU - De Cosmo, Salvatore

AU - Mazzoccoli, Gianluigi

AU - Rotella, Carlo Maria

N1 - Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

PY - 2017/7/5

Y1 - 2017/7/5

N2 - BACKGROUND: Diabetic Cardiomiopathy (DC) has been defined as a distinct entity characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient in the absence of other causes for Cardiomiopathy, such as coronary artery disease (CAD), hypertension (HTN), or valvular heart disease. Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form of coronary artery disease (CAD), cardiac autonomic neuropathy or DC. The prevalence of cardiac failure is high in the diabetic population and DC is a common, but underestimated cause of heart failure in diabetes. The strong association between diabetes and heart failure has fueled intense human and animal research aimed at identifying the mechanisms underlying diabetic myocardial disease. Even if significant progress have been made, the precise pathogenesis of diabetic Cardiomiopathy is yet to be clearly defined. Hyperglycemia, dyslipidemia and inflammation are thought to play key roles in the generation of reactive oxygen or nitrogen species which are in turn involved.METHODS: we have reviewed the up-to-date scientific literature addressing these issues.RESULTS: The myocardial interstitium undergoes alterations resulting in abnormal contractile function noted in DC. In the early stages of the disease diastolic dysfunction is the only abnormality, but systolic dysfunction supervenes in the later stages with impaired left ventricular ejection fraction. Transmitral Doppler echocardiography is usually used to assess diastolic dysfunction, but tissue Doppler Imaging and Cardiac Magnetic Resonance Imaging are being increasingly used for early detection of DC. Diabetic patients with microvascular complications show the strongest association between diabetes and Cardiomiopathy, an association that parallels the duration and severity of hyperglycemia.CONCLUSIONS: The management of DC involves improvement in lifestyle, control of glucose and lipid abnormalities, together with treatment of hypertension and CAD, if present.

AB - BACKGROUND: Diabetic Cardiomiopathy (DC) has been defined as a distinct entity characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient in the absence of other causes for Cardiomiopathy, such as coronary artery disease (CAD), hypertension (HTN), or valvular heart disease. Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form of coronary artery disease (CAD), cardiac autonomic neuropathy or DC. The prevalence of cardiac failure is high in the diabetic population and DC is a common, but underestimated cause of heart failure in diabetes. The strong association between diabetes and heart failure has fueled intense human and animal research aimed at identifying the mechanisms underlying diabetic myocardial disease. Even if significant progress have been made, the precise pathogenesis of diabetic Cardiomiopathy is yet to be clearly defined. Hyperglycemia, dyslipidemia and inflammation are thought to play key roles in the generation of reactive oxygen or nitrogen species which are in turn involved.METHODS: we have reviewed the up-to-date scientific literature addressing these issues.RESULTS: The myocardial interstitium undergoes alterations resulting in abnormal contractile function noted in DC. In the early stages of the disease diastolic dysfunction is the only abnormality, but systolic dysfunction supervenes in the later stages with impaired left ventricular ejection fraction. Transmitral Doppler echocardiography is usually used to assess diastolic dysfunction, but tissue Doppler Imaging and Cardiac Magnetic Resonance Imaging are being increasingly used for early detection of DC. Diabetic patients with microvascular complications show the strongest association between diabetes and Cardiomiopathy, an association that parallels the duration and severity of hyperglycemia.CONCLUSIONS: The management of DC involves improvement in lifestyle, control of glucose and lipid abnormalities, together with treatment of hypertension and CAD, if present.

KW - Journal Article

U2 - 10.2174/0929867324666170705111356

DO - 10.2174/0929867324666170705111356

M3 - Article

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

ER -